A new study finds that men with diabetes have areas of muscle thinning in their gluteus maximus while women show pockets of fat buildup within the muscle.

Opportunities in the SMA market include leveraging the launch of new myostatin inhibitors, expanding Zolgensma formulations to increase patient eligibility, and capitalizing on cheap nusinersen ...

South Indian star Samantha Ruth Prabhu revealed her myositis diagnosis in October 2022, a rare autoimmune disease causing ...

Annexon Inc. research and ratings by Barron's. View ANNX revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

Marley was given Zolgensma, a life-changing gene therapy drug, at 16 months. According to SMA UK, the drug delivers a healthy copy of the affected gene to the body, but timing is critical because ...

Sara Ghanem and Samar Farag remember the exact moment they became friends, and their lives changed forever. With the constant sound of machines beeping in the background and the hustle and bustle of ...

William, 16, supports Ellie, 15, who has spinal muscular atrophy, alongside his volunteer work with the Scouts, and other jobs - including being the milkman for his village of Kirkby Malzeard, near ...

SCHAUMBURG, Ill., Nov. 26, 2025 /PRNewswire/ -- Cure SMA, the leading nonprofit organization dedicated to supporting those impacted by spinal muscular atrophy (SMA), welcomes the FDA approval of ...

The FDA has approved Itvisma for the treatment of children two years and older, teens and adults living with spinal muscular ...

In today’s Pharma Pulse, the federal government prepares to unveil newly negotiated Medicare prices for 15 high-cost drugs, while Novartis receives FDA approval for Itvisma, a one-time gene therapy ...

Now, it’s worth noting Stock Advisor’s total average return is 1,002% — a market-crushing outperformance compared to 190 % ...

The U.S. Food and Drug Administration has approved Novartis' gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday.